Activity and spectrum of BMS 284756, a new des-F (6) quinolone, tested against strains of ciprofloxacin-resistant Gram-positive cocci

Diagnostic Microbiology and Infectious Disease

Volumn 39, Issue 2, 2001, Pages 133-135

  Jones, Ronald N ^a,b   Pfaller, M A ^a   Stilwell, M ^a  

^a UNIVERSITY OF IOWA   (United States)

^b The JONES Group   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; GARENOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; QUINOLONE DERIVATIVE;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIUM ISOLATION; DRUG POTENCY; GRAM POSITIVE BACTERIUM; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL;

ANTI-INFECTIVE AGENTS; CIPROFLOXACIN; DRUG RESISTANCE, MICROBIAL; FLUOROQUINOLONES; GRAM-POSITIVE BACTERIAL INFECTIONS; GRAM-POSITIVE COCCI; HUMANS; INDOLES; MICROBIAL SENSITIVITY TESTS; QUINOLONES;

EID: 0035089287     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0732-8893(00)00233-9     Document Type: Article

References (5)

1. Antibacterial spectrum of a novel des-Fluoro (6) quinolone, BMS-284756
2. T-3811, a novel des-F(6)-quinolone: Synthesis and in vitro activity of 7-(isoindolin-5-yl) derivatives
3. In vitro and in vivo antimicrobial activities of T-3811ME, a novel des-F(6)-quinolone